Arthur He CFA
Stock Analyst at H.C. Wainwright
(4.83)
# 449
Out of 5,020 analysts
133
Total ratings
52.8%
Success rate
31.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arthur He CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VERA Vera Therapeutics | Reiterated: Buy | $90 | $32.29 | +178.72% | 14 | Oct 1, 2026 | |
| IMA ImageneBio | Maintained: Buy | $28 | $4.58 | +511.35% | 2 | Oct 1, 2026 | |
| PRME Prime Medicine | Reiterated: Buy | $8 | $3.06 | +161.87% | 19 | Oct 1, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Buy | $185 | $60.55 | +205.56% | 20 | Oct 1, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | $55 | $14.04 | +291.74% | 7 | Oct 1, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Reiterated: Buy | $25.55 | $12.09 | +111.37% | 15 | Sep 25, 2026 | |
| ADAG Adagene | Reiterated: Buy | $7 | $3.20 | +118.75% | 19 | Sep 14, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $25 | $7.23 | +245.78% | 22 | Sep 14, 2026 | |
| AUPH Aurinia Pharmaceuticals | Reiterated: Buy | $17 | $16.20 | +4.97% | 3 | Feb 27, 2026 | |
| ADAPY Adaptimmune Therapeutics plc | Downgraded: Hold | n/a | $0.038 | n/a | 8 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $22.77 | n/a | 1 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27.00 → $35.00 | $30.14 | n/a | 3 | Apr 3, 2023 |
Vera Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $90
Current: $32.29
Upside: +178.72%
ImageneBio
Oct 1, 2026
Maintained: Buy
Price Target: $28
Current: $4.58
Upside: +511.35%
Prime Medicine
Oct 1, 2026
Reiterated: Buy
Price Target: $8
Current: $3.06
Upside: +161.87%
Nektar Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $185
Current: $60.55
Upside: +205.56%
Jade Biosciences
Oct 1, 2026
Reiterated: Buy
Price Target: $55
Current: $14.04
Upside: +291.74%
Satellos Bioscience Inc.
Sep 25, 2026
Reiterated: Buy
Price Target: $25.55
Current: $12.09
Upside: +111.37%
Adagene
Sep 14, 2026
Reiterated: Buy
Price Target: $7
Current: $3.20
Upside: +118.75%
Solid Biosciences
Sep 14, 2026
Reiterated: Buy
Price Target: $25
Current: $7.23
Upside: +245.78%
Aurinia Pharmaceuticals
Feb 27, 2026
Reiterated: Buy
Price Target: $17
Current: $16.20
Upside: +4.97%
Adaptimmune Therapeutics plc
Jul 29, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.038
Upside: n/a
Jun 21, 2024
Reiterated: Buy
Price Target: n/a
Current: $22.77
Upside: n/a
Apr 3, 2023
Reiterated: Buy
Price Target: $27.00 → $35.00
Current: $30.14
Upside: n/a